Home
Search
BIO International Convention   |   June 16-19, 2025

Speakers & Presenters

All Speakers
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
Company Type
  • Show All
Main Therapeutic Focus
  • Show All
Development Phase of Primary Product
  • Show All
Search Speakers
All Speakers
Filter by letter
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Results
Shawn Carlson
HEAD OF MARKET ACCESS, ROCHE DIAGNOSTICS
Prescient Diagnostics: Implications for Product Development and Reimbursement
Chris Carpenter
EXECUTIVE PARTNER, PRIVATE EQUITY, SOFINNOVA INVESTMENTS
The Evolving Landscape of Immunotherapy in Solid Cancers
Menlo Park, California, United States
Juan Carter
OUTREACH MANAGER, GIFFORDS CENTER FOR VIOLENCE INTERVENTION
The Life Sciences Industry: Taking a Public Health Approach to Ending the Gun Violence Epidemic
Patrizia Cavazzoni, MD
DIRECTOR, CENTER FOR DRUG EVALUATION AND RESEARCH, FDA
FDA Town Hall
Meenakshy Chakravorty, JD
SENIOR COUNSEL, DIGITAL AND DEVICES IP, SANOFI
IP for AI: Expanding a Biopharma IP Portfolio to Protect AI and Data Innovations
Boston, Massachusetts, United States
Placeholder Photo
Sherine Chan
CEO AND CO-FOUNDER, NEUROENE THERAPEUTICS
Neuroene Therapeutics
Ben Chandhok
DIRECTOR OF STATE PUBLIC POLICY AND GOVERNMENT RELATIONS, ALNYLAM PHARMACEUTICALS
Business Critical: Building a State/Regional Advocacy Arm
Rachna Chandora
ASSOCIATE VICE PRESIDENT FOR NONINFECTIOUS DISEASE PROGRAMS, CDC FOUNDATION
Navigating Patient Access Barriers to Solve Public Health Challenges in Cardiovascular Disease
Hemmie Chang
PARTNER & CO-CHAIR, LIFE SCIENCES GROUP; CHAIR, LICENSING & STRATEGIC ALLIANCES, FOLEY HOAG LLP
DTx 2.0: The Promise of Digital Therapeutics
Placeholder Photo
Katerina Chatzi
CEO, PROMAKHOS THERAPEUTICS
Promakhos Therapeutics